Elucidating the mechanisms by which PLK1 inhibition causes anemia provides valuable insights for the prevention and treatment of anemia in clinical settings, while also offering new strategies for the development of cancer therapeutics and combinatory treatments. This evidence concerns the gene PLK1 and anemia.